ImpediMed Limited

ASX:IPD.AX

0.07 (AUD) • At close October 17, 2024
Bedrijfsnaam ImpediMed Limited
Symbool IPD.AX
Munteenheid AUD
Prijs 0.065
Beurswaarde 131,500,850
Dividendpercentage 0%
52-weken bereik 0.042 - 0.16
Industrie Medical Devices
Sector Healthcare
CEO Mr. Richard P. Valencia
Website https://www.impedimed.com

An error occurred while fetching data.

Over ImpediMed Limited

ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS

Vergelijkbare Aandelen

Mach7 Technologies Limited logo

Mach7 Technologies Limited

M7T.AX

0.54 AUD

Alcidion Group Limited logo

Alcidion Group Limited

ALC.AX

0.057 AUD

Next Science Limited logo

Next Science Limited

NXS.AX

0.195 AUD

Genetic Signatures Limited logo

Genetic Signatures Limited

GSS.AX

0.675 AUD

Oneview Healthcare PLC logo

Oneview Healthcare PLC

ONE.AX

0.34 AUD

EMVision Medical Devices Ltd logo

EMVision Medical Devices Ltd

EMV.AX

2.02 AUD

Recce Pharmaceuticals Ltd logo

Recce Pharmaceuticals Ltd

RCE.AX

0.56 AUD

Volpara Health Technologies Limited logo

Volpara Health Technologies Limited

VHT.AX

1.145 AUD

Probiotec Limited logo

Probiotec Limited

PBP.AX

2.98 AUD

Financiële Gegevens

Cijfers zijn in miljoenen (AUD)

Cijfers zijn in miljoenen (AUD)